Bank of Montreal
ATNM icon

Bank of Montreal’s Actinium Pharmaceuticals ATNM Stock Holding History

Bank of Montreal’s Portfolio ATNM Stock Details ATNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-83
Closed -$1K – 4161
2017
Q3 		$1K Hold
83
– – ﹤0.01% 4083
2017
Q2 		$3K Hold
83
– – ﹤0.01% 3939
2017
Q1 		$4K Hold
83
– – ﹤0.01% 3726
2016
Q4 		$3K Hold
83
– – ﹤0.01% 3814
2016
Q3 		$3K Hold
83
– – ﹤0.01% 3788
2016
Q2 		$4K Hold
83
– – ﹤0.01% 3774
2016
Q1 		$5K Hold
83
– – ﹤0.01% 3771
2015
Q4 		$8K Buy
+83
New +$5.52K ﹤0.01% 3657

Other funds holding ATNM

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Bank of Montreal's ATNM Position: Q4 2017 in Review

Bank of Montreal sold out of Actinium Pharmaceuticals (ATNM) in Q4 2017, closing a stake of 83 shares — an estimated $1K sold.

Bank of Montreal first reported a position in ATNM in Q4 2015 and held it in 8 quarters. The position peaked at $8K in Q4 2015. 28 funds tracked by Wall St. Rank hold ATNM as of Q4 2017.

  • Bank of Montreal reported no remaining Actinium Pharmaceuticals position as of Q4 2017 after selling out during the quarter.
  • Bank of Montreal sold 83 Actinium Pharmaceuticals shares in Q4 2017, an estimated $1K.
  • Bank of Montreal first reported a position in Actinium Pharmaceuticals in Q4 2015 and held it in 8 quarters.
  • Bank of Montreal's Actinium Pharmaceuticals position peaked at $8K in Q4 2015.
  • 28 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q4 2017.

Based on Bank of Montreal's 13F filing for Q4 2017, filed 16 Jan 2018.